There is growing recognition that obesity is common and represents a significant detriment to the health of companion animals in a manner similar to that by which it is affecting the human population. As is the case for other species, obesity appears to promote insulin resistance in horses and it is through this pathophysiological process that many of the adverse medical consequences of obesity are being characterized. Equine medical conditions that have been described in the context of obesity and insulin resistance differ from those in humans. Chronic human conditions that have been attributed to obesity and insulin resistance, such as atherosclerosis and diabetes mellitus, are rarely described in obese horses. Significant current interest is centered on the recognition that insulin resistance plays a role in the pathogenesis of laminitis, a potentially severe and debilitating cause of lameness in the equine species. Other equine medical conditions that are more likely in obese, insulin-resistant individuals include hyperlipemia (hepatic lipidosis) and developmental orthopedic disease (osteochondrosis). Pituitary pars intermedia dysfunction (equine Cushing's syndrome) represents another common endocrinopathic condition of older horses associated with insulin resistance. This review presents an introductory overview of the present understanding of obesity and insulin resistance and how these conditions may be associated with disease conditions in horses.
WyseCAMcNieKATannahilVJMurrayJKLoveS. Prevalence of obesity in riding horses in Scotland. Vet Rec.2008;162 (18): 590–1.
2.
FrankNElliottSBBostonRC. Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am J Vet Res.2008;69 (1): 76–81.
3.
PrattSEGeorRJMcCutcheonLJ. Effects of dietary energy source and physical conditioning on insulin sensitivity and glucose tolerance in standardbred horses. Equine Vet JSuppl.2006;(36):579–84.
4.
JohnsonPJGanjamVKMesserNTTurkJRKeislerDHBuffPRWiedmeyerCE. The obesity paradigm: an introduction to the emerging discipline of adipobiology. Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners; 2006 Dec 2–6; San Antonio, TX. p. 41–50.
5.
DonaldsonMTMcDonnellSMSchanbacherBJLambSVMcFarlaneDBeechJ. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J Vet Intern Med.2005;19 (2): 217–22.
6.
SsewannyanaELincolnGALintonEALowryPJ. Regulation of the seasonal cycle of beta-endorphin and ACTH secretion into the peripheral blood of rams. J Endocrinol.1990;124 (3): 443–54.
7.
MesserNTJohnsonPJ. Evidence-based literature pertaining to thyroid dysfunction and Cushing's syndrome in the horse. Vet Clin North Am Equine Pract.2007;23 (2): 329–64.
8.
Fernandez-RealJM. Genetic predispositions to low-grade inflammation and type 2 diabetes. Diabetes Technol Ther.2006;8 (1): 55–66.
9.
NeelJV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”?. Am J Hum Genet.1962;14: 353–362.
10.
DysonMCAllooshMBoullionRDMokelkeEASturekM. Glucose intolerance and insulin resistance in Ossabaw compared to Yucatan swine. FASEB J.2004;18: A1224–5.
11.
MayerJJBrisbinILJr.Wild pigs of the United States: their history, morphology, and current status. Athens, GA: University of Georgia Press; 1991.
12.
BuhlingerCAWangsnessPJMartinRJZieglerJH. Body composition, in vitro lipid metabolism and skeletal muscle characteristics in fast-growing, lean and in slow growing, obese pigs at equal age and weight. Growth.1978;42 (2): 225–36.
13.
MartinRJGobbleJLHartsockTHGravesHBZieglerJH. Characterization of an obese syndrome in the pig. Proc Soc Exp Biol Med.1973;143: 198–203.
14.
DysonMMokelkeEAVuchetichJSturekM. Use of computed tomography to evaluate intra-abdominal fat stores in a swine model of the metabolic syndrome. FASEB J.2005;19: A191–2.
15.
GerrityRGNatarajanRNadlerJLKimseyT. Diabetes-induced accelerated atherosclerosis in swine. Diabetes.2001;50 (7): 1654–65.
16.
TreiberKHKronfeldDSHessTMByrdBMSplanRKStaniarWB. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc.2006;228 (10): 1538–45.
17.
FieldJRJeffcottLB. Equine laminitis—another hypothesis for pathogenesis. Med Hypotheses.1989;30 (3): 203–10.
18.
FreestoneJFBeadleRShoemakerKBessinRTWolfsheimerKJChurchC. Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake. Equine Vet J.1992;24 (3): 187–90.
19.
AlfordPGellerSRichardsonBSlaterMHonnasCForemanJRobinsonJMesserMRobertsMGobleDHoodDChaffinM. A multicenter, matched case-control study of risk factors for equine laminitis. Prev Vet Med.2001;49 (3–4): 209–222.
20.
LeeSBachaFGungorNArslanianSA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr.2006;148 (2): 188–94.
21.
HennekeDRPotterGDKreiderJLYeatesBF. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J.1983;15 (4): 371–2.
22.
DonaldsonMTMcFarlaneDJorgensenAJBeechJ. Correlation between plasma alpha-melanocyte-stimulating hormone concentration and body mass index in healthy horses. Am J Vet Res.2004;65 (11): 1469–73.
23.
KearnsCFMcKeeverKHJohn-AlderHAbeTBrechueWF. Relationship between body composition, blood volume and maximal oxygen uptake. Equine Vet JSuppl.2002;34: 485–490.
24.
KaneRAFisherMParrettDLawrenceLM. Estimating fatness in horses. Proceedings of the 10th Equine Nutrition and Physiology Society Symposium; 1989; Fort Collins, CO. p. 127–31.
25.
WesterveltRGStoufferJRHintzHFSchryverHF. Estimating fatness in horses and ponies. J Anim Sci1976;43: 781–5.
AllanFJPfeifferDUJonesBREsslemontDHWisemanMS. A cross-sectional study of risk factors for obesity in cats in New Zealand. Prev Vet Med.2000;46 (3): 183–96.
28.
RobertsonID. The association of exercise, diet and other factors with owner-perceived obesity in privately owned dogs from metropolitan Perth, WA. Prev Vet Med.2003;58 (1–2): 75–83.
29.
TreiberKHKronfeldDSHessTMByrdBMSplanRKStaniarWB. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc.2006;228 (10): 1538–45.
30.
CoffmanJRCollesCM. Insulin tolerance in laminitic ponies. Can J Comp Med.1983;47 (3): 347–51.
31.
FieldJRJeffcottLB. Equine laminitis—another hypothesis for pathogenesis. Med Hypotheses.1989;30 (3): 203–10.
32.
JohnsonPJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract.2002;18 (2): 271–93.
33.
KearnsCFMcKeeverKHKumagaiKAbeT. Fat-free mass is related to one-mile race performance in elite standardbred horses. Vet J.2002;163 (3): 260–6.
34.
LawrenceLMJacksonSKlineKMoserLPowellDBielM. Observations on body weight and condition of horses in a 150-mile endurance ride. J Equine Vet Sci.1992;12: 320–4.
35.
GarlinghouseSEBurrillMJ. Relationship of body condition score to completion rate during 160 km endurance races. Equine Vet JSuppl.1999;30: 591–5.
36.
CymbalukNFChristisonGI. Environmental effects on thermoregulation and nutrition of horses. Vet Clin North Am Equine Pract.1990;6 (2): 355–72.
37.
HennekeDRPotterGDKreiderJL. Body condition during pregnancy and lactation and reproductive efficiency of mares. Theriogenology.1984;21: 897–909.
38.
NagyPHuszeniczaGJuhászJKulcsárMSoltiLReiczigelJAbaváryK. Factors influencing ovarian activity and sexual behavior of postpartum mares under farm conditions. Theriogenology.1998;50 (7): 1109–19.
39.
FitzgeraldBPReedySESessionsDRVickMMMurphyBA. Obesity disrupts the duration of the estrous cycle in the mare. J Anim Sci.2003;81: 102.
40.
Garcia-SecoEWilsonDAKramerJKeeganKGBransonKRJohnsonPJTylerJW. Prevalence and risk factors associated with outcome of surgical removal of pedunculated lipomas in horses: 102 cases (1987–2002). J Am Vet Med Assoc.2005;226 (9): 1529–37.
41.
HoffmanRMBostonRCStefanovskiDKronfeldDSHarrisPA. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci.2003;81 (9): 2333–42.
42.
VickMMAdamsAAMurphyBASessionsDRHorohovDWCookRFSheltonBJFitzgeraldBP. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci.2007;85 (5): 1144–55.
43.
McGowanCMFrostRPfeifferDUNeigerR. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J.2004;36 (3): 295–8.
44.
ReevesHJLeesRMcGowanCM. Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies. Vet Rec.2001;149 (15): 449–52.
45.
JohnsonPJMesserNTGanjamVK. Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine Vet J.2004;36 (3): 194–8.
46.
RalstonS. Hyperglycemia/hyperinsulinemia after feeding a meal of grain to young horses with osteochondrosis dissecans (OCD) lesions. Pferdeheilkunde.1996;12: 320–2.
47.
ReidSWMohammedHO. Survival analysis approach to risk factors associated with hyperlipemia in donkeys. J Am Vet Med Assoc.1996;209 (8): 1449–52.
48.
JohnsonPJScottyNCWiedmeyerCMesserNTKreegerJM. Diabetes mellitus in a domesticated Spanish Mustang mare. J Am Vet Med Assoc.2004;226 (4): 584–8.
49.
TóthFFrankNElliottSBGeorRJBostonRC. Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses. Am J Vet Res.2008;69 (1): 82–8.
50.
JánosiSHuszeniczaGKulcsárMKóródiP. Endocrine and reproductive consequences of certain endotoxin-mediated diseases in farm mammals: a review. Acta Vet Hung.1998;46 (1): 71–84.
51.
NilssonPMEngströmGHedbladB. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects—a population-based study comparing three different definitions. Diabet Med.2007;24 (5): 464–72.
52.
CarterRAGeorRJStaniarW BurtonCubittTAHarrisPA. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. Vet J.2008 Apr 25.
53.
BaileySRHabershon-ButcherJLRansomKJElliottJMenzies-GowNJ. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res.2008;69 (1): 122–9.
54.
GarnerHECoffmanJRHahnAWAckermanNJohnsonJH. Equine laminitis and associated hypertension: a review. J Am Vet Med Assoc.1975;166 (1): 56–7.
55.
RughKSGarnerHESprouseRFHatfieldDG. Left ventricular hypertrophy in chronically hypertensive ponies. Lab Anim Sci.1987;37 (3): 335–8.
56.
VickMMMurphyBASessionsDRReedySEKennedyELHorohovDWCookRFFitzgeraldBP. Effects of systemic inflammation on insulin sensitivity in horses and inflammatory cytokine expression in adipose tissue. Am J Vet Res.2008;69 (1): 130–9.
57.
VickMMAdamsAAMurphyBASessionsDRHorohovDWCookRFSheltonBJFitzgeraldBP. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci.2007;85 (5): 1144–55.
58.
FirshmanAMValbergSJ. Factors affecting clinical assessment of insulin sensitivity in horses. Equine Vet J.2007;39 (6): 567–75.
59.
PowellDMReedySESessionsDRFitzgeraldBP. Effect of short-term exercise training on insulin sensitivity in obese and lean mares. Equine Vet JSuppl.2002;(34):81–4.
60.
TileyHAGeorRJMcCutcheonLJ. Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. Am J Vet Res.2007;68 (7): 753–9.
61.
FowderALBarnesRJComlineRSSilverM. Pancreatic beta-cell function in the fetal foal and mare. J Endocrinol.1980;87 (2): 293–301.
62.
PassMAPollittSPollittCC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?Equine Vet JSuppl.1998;(26):133–8.
63.
JohnsonPJMesserNTSlightSHWiedmeyerCBuffPGanjamVK. Endocrinopathic laminitis in the horse. Clin Techniques Equine Pract.2004;3 (1): 45–56.
64.
BaileySRMenzies-GowNJMarrCMElliottJ. The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Equine Vet J.2004;36 (3): 267–72.
65.
BaileySRCunninghamFMElliottJ. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse. Equine Vet J.2000;32 (6): 497–504.
66.
MilinovichGJBurrellPCPollittCCBouvetATrottDJ. Streptococcus henryi sp. nov. and Streptococcus caballi sp. nov., isolated from the hindgut of horses with oligofructose-induced laminitis. Int J Syst Evol Microbiol.2008;58 (Pt 1): 262–6.
67.
AllenDJr.ClarkESMooreJNPrasseKW. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res.1990;51 (12): 1930–4.
68.
LoftusJPBelknapJKBlackSJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopathol.2006;113 (3–4): 267–76.
69.
BlackSJLunnDPYinCHwangMLenzSDBelknapJK. Leukocyte emigration in the early stages of laminitis. Vet Immunol Immunopathol.2006;109 (1–2): 161–6.
70.
EadesSCStokesAMJohnsonPJLeBlancCJGanjamVKBuffPRMooreRM. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am J Vet Res.2007;68 (1): 87–94.
71.
BaileySRMenzies-GowNJHarrisPAHabershon-ButcherJLCrawfordCBerhaneYBostonRCElliottJ. Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis. J Am Vet Med Assoc.2007;231 (9): 1365–73.
72.
ZarkovicMBeleslinBCiricJPenezicZStojkovicMTrbojevicBDrezgicMSavicS. Glucocorticoid effect on insulin sensitivity: a time frame. J Endocrinol Invest.2008;31 (3): 238–42.
73.
KotelevtsevYHolmesMCBurchellAHoustonPMSchmollDJamiesonPBestRBrownREdwardsCRSecklJRMullinsJJ. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA.1997;94 (26): 14924–9.
74.
MasuzakiHPatersonJShinyamaHMortonNMMullinsJJSecklJRFlierJS. A transgenic model of visceral obesity and the metabolic syndrome. Science.2001;294 (5549): 2166–70.
75.
JohnsonPJGanjamVKSlightSHKreegerJMMesserNT. Tissue-specific dysregulation of cortisol metabolism in equine laminitis. Equine Vet J.2004;36 (1): 41–5.
76.
SchottHCIIGravesEARefsalKRNachreinerRJEberhartSWJohnsonPJSlightSHMesserNTGanjamVK. Treatment of pituitary pars intermedia dysfunction (classic Cushing's disease) and metabolic syndrome (peripheral Cushing's syndrome) in horses. In: HillierAAidenPFosterAPKwochkaKW, editors. Advances in veterinary dermatology 5. Proceedings of the 5th World Congress of Veterinary Dermatology; 2004; Hofburg Conference Center, Vienna, Austria. Blackwell Publishing. p. 159–69.
77.
AsplinKESillenceMNPollittCCMcGowanCM. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J.2007;174 (3): 530–5.
78.
KemppainenRZerbeCSartinJ. Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells. Endocrinology.1989;124 (5): 2208–17.
79.
KemppainenRJPetersonME. Regulation of alpha-melanocyte-stimulating hormone secretion from the pars intermedia of domestic cats. Am J Vet Res.1999;60 (2): 245–9.
80.
McFarlaneDDybdalNDonaldsonMTMillerLCribbAE. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol.2005;17 (2): 73–80.
81.
McFarlaneD. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease. Ageing Res Rev.2007;6 (1): 54–63.
82.
DaramSRBoppidiH. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome. Postgrad Med.2008;120 (2): E01–7.
83.
LawlerDFLarsonBTBallamJMSmithGKBieryDNEvansRHGreeleyEHSegreMStoweHDKealyRD. Diet restriction and ageing in the dog: major observations over two decades. Br J Nutr.2008;99 (4): 793–805.
84.
SlingerlandLIRobbenJHvan HaeftenTWKooistraHSRijnberkA. Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res.2007;39 (5): 341–6.
85.
TreiberKHKronfeldDSHessTMBostonRCHarrisPA. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res.2005;66 (12): 2114–21.
86.
EilerHFrankNAndrewsFMOliverJWFecteauKA. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res.2005;66 (9): 1598–604.
87.
WiedmeyerCEJohnsonPJCohnLAMeadowsRLKerlMETessmanRKPerlisJDeClueAE. Evaluation of a continuous glucose monitoring system for use in veterinary medicine. Diabetes Technol Ther.2005;7 (6): 885–95.
88.
WiedmeyerCEJohnsonPJCohnLAMeadowsRL. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc.2003;223 (7): 987–92.
89.
CordainLMillerJBEatonSBMannNHoltSHSpethJD. Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am J Clin Nutr.2000;71 (3): 682–92.
90.
CordainLEatonSBSebastianAMannNLindebergSWatkinsBAO'KeefeJHBrand-MillerJ. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr.2005;81 (2): 341–54.
91.
BoothFWChakravarthyMVGordonSESpangenburgEE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol.2002;93 (1): 3–30.
92.
EatonSB. The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition?. Proc Nutr Soc.2006;65 (1): 1–6.
